Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63 [PMID: 22228971 DOI: 10.3748/wjg.v18.i1.55]
Corresponding Author of This Article
Abdulrahman A Aljumah, MD, FRCPI Consultant Hepatologist and Liver Transplant Physician Head, Division of Hepatology, Department of Hepatobiliary Sciences and Liver Transplantation, King Abdulaziz Medical City and King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, PO Box 225264, Riyadh 11324, Saudi Arabia. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
HCV: Hepatitis C virus; CI: Conventional interferon; PEG-IFN: Pegylated interferon; R: Ribavirin; CNI: Calcineurin inhibitors; C: Cellcept; S: Steroids; Aza:azathioprine; ETR: End of treatment response; SVR: Sustained virological response; NR: Not reported; NS: Not specified.
1Five patients developed acute renal failure, but biopsy did not confirm rejection.
2CI changed to PEG-IFN in 3 patients but study did not specify these patients.
3In this study 8 patients received ribavirin alone without interferon, so they were not included. 3Four patients developed severe renal dysfunction, only one patient biopsied and showed chronic allograft nephropathy.
Citation: Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, Al Qurashi SH, Al Ghamdi GA, Al Hejaili FF, Al Balwi MA, Al Sayyari AA. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World J Gastroenterol 2012; 18(1): 55-63